Sensitivity of transplantable rat leukemia, DBLA-6, to antitumor agents.
D000476:Alkanesulfonates / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002460:Cell Line; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D007942:Leukemia, Experimental / Q000139:chemically induced / Q000188:drug therapy*; D007958:Leukocyte Count; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000627:therapeutic use; D009368:Neoplasm Transplantation; D009607:Nitrosourea Compounds; D051381:Rats; D013291:Streptococcus; D014105:Tosyl Compounds / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000476:Alkanesulfonates; D000970:Antineoplastic Agents; D001713:Biphenyl Compounds; D008937:Mitomycins; D009607:Nitrosourea Compounds; D014105:Tosyl Compounds; D003561:Cytarabine; D001761:Bleomycin; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D008727:Methotrexate; D003630:Daunorubicin